ProQuest Investments IV, L.P. is 10% Owner at EAGLE PHARMACEUTICALS, INC. (EGRX). They have made 15 open-market trades across 3 companies since 2014, most recently 2017-04-25.
CIK 0000827871
2 open-market purchases totalling $7.5M since 2014, against 13 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 69% | 69% | 54% |
| Avg Move | -16.9% | +0.9% | +8.8% |
| Scored | 13 | 13 | 13 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EGRX | SELL | 2017-04-25 | 2017-04-27 | $88.38 | $4.8M | -1.9% | -17.8% | -41.2% |
| EGRX | SELL | 2016-11-07 | 2016-11-09 | $79.32 | $24.0M | -6.0% | -9.7% | -17.3% |
| EGRX | SELL | 2016-09-30 | 2016-10-04 | $70.06 | $1.5M | -8.3% | +2.3% | +15.2% |
| EGRX | SELL | 2016-09-21 | 2016-09-23 | $66.17 | $13.2M | +5.6% | -0.7% | +15.6% |
| EGRX | SELL | 2016-08-24 | 2016-08-25 | $62.78 | $722K | +5.8% | +13.1% | +36.3% |
| EGRX | SELL | 2016-08-23 | 2016-08-25 | $63.14 | $1.1M | +5.8% | +13.1% | +36.3% |
| EGRX | SELL | 2016-08-23 | 2016-08-25 | $63.00 | $1.8M | +5.8% | +13.1% | +36.3% |
| EGRX | SELL | 2016-08-15 | 2016-08-17 | $61.88 | $2.8M | -1.1% | -0.1% | +34.3% |
| AGRX | BUY | 2016-01-27 | 2016-01-29 | $6.35 | $2.5M | -1.3% | -5.7% | -5.9% |
| IMDZ | SELL | 2015-04-22 | 2015-04-24 | $26.81 | $2.2M | -45.2% | -0.3% | -0.3% |
| IMDZ | SELL | 2015-04-06 | 2015-04-08 | $26.72 | $200K | -45.2% | -0.3% | -0.3% |
| IMDZ | SELL | 2015-03-24 | 2015-03-26 | $27.64 | $502K | -45.2% | -0.3% | -0.3% |
| IMDZ | SELL | 2015-03-19 | 2015-03-23 | $27.52 | $1.2M | -45.2% | -0.3% | -0.3% |
| IMDZ | SELL | 2015-03-05 | 2015-03-09 | $25.45 | $1.0M | -45.2% | -0.3% | -0.3% |
| EGRX | BUY | 2014-02-18 | 2014-02-20 | $15.00 | $5.0M | -8.4% | -0.4% | -0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.